Come up with a name for your new list and we'll add to it:
UnNamed raised a round of funding on December 21, 2016. Investors include
Harvard Life Lab.
UnNamed's technologies enable living cells to sense and respond to chemicals. This is done by engineering proteins to become dependent on binding to a target molecule, allowing for the generation of n…